PHILADELPHIA, PA / ACCESSWIRE / June 25, 2014 / Olfactory Biosciences Corp (OLFC) is pleased to announce that to comply with FDA regulations, the company has changed the name of the NOXO Autism Balm(TM)
to new natural and improved NOXO Sensory product
with a new topical delivery system and is now available - NOXO Sensory Balm(TM) http://noxoinfo.com/sensory
New NOXO Sensory Balm(TM) contains therapeutic natural ingredients, which are delivered to the olfactory receptors by topical application under the nose. The new NOXO can provide relief from environmental odors and sensory processing issues that have the potential to trigger maladaptive coping responses.
Hypersensitivity, typically seen in its most severe form in people with autism, can make everyday life very uncomfortable or even painful. http://noxoinfo.com/sensory
Regardless of whether a child, teen or adult has autism, sensory processing disorder or another condition, both the person and family members, teachers and other caregivers need help which NOXO Sensory Balm(TM) may provide.
Once NOXO Sensory Balm(TM)
is delivered to the olfactory receptors, the NOXO molecules transport their "messages" directly to the brain's emotional center–the limbic system–which can improve behavior by reducing the intensity as well as the way the brain processes sensory messages. NOXO Sensory Balm(TM) was developed by Olfactory
Biosciences Corp using the company’s own science, that of its partner Flavors and Fragrances Systems, Inc., and the science of 2004 NOBEL Prize in Medicine Winners Richard Axel and Linda Buck. The company has been successful in targeting specific olfactory receptors with the company’s unique products resulting in the desired behavioral modifications.
This release is also in response to the many satisfied customers that called and could not find the Autism Balm and were not aware of the change
For further information and to BUY NOXO Sensory Balm(TM) NOW, go to http://www.noxoinfo.com/sensory
Ingredients: A special company formulation of Phytonutrients and Phytochemicals taken from plants, flowers, roots and seeds. All ingredients are in a high quality white petrolatum that complies with white petrolatum USP requirements and FDA requirements (21 CFR 172.880)
**Our products are free of bee pollen, lactose, peanuts, tree nuts, shellfish, gelatin, contain all organic ingredients, and are free of allergens such as milk, wheat, gluten**
About Olfactory Biosciences Corp.
Olfactory Biosciences Corp.'s NOXO division develops products targeting olfactory receptors in the nose for the desired effect. These alternative medicine wellness products can modify behavior or provide relief to common behavior challenges such as anxiety or help with weight control. http://www.noxoinfo.com/investor
FORWARD-LOOKING STATEMENTS "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:
Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company’s business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such
forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company’s products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company’s Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Source: Olfactory Biosciences Corp.
Leave a comment...